Sign up to save your podcasts
Or
Share Clinical update on AMG 420, an anti-BCMA BiTE®
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Clinical update on AMG 420, an anti-BCMA BiTE®
In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE®
This talk addresses the:
Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy)
Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com
View all episodes
By Pharma Talk Radio
4.5
1717 ratings
In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE®
This talk addresses the:
Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy)
Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com